You just read:

Quark Pharmaceuticals RNAi Drug Succeeds in Phase 2 Study to Prevent Acute Kidney Injury Following Cardiac Surgery

News provided by

Quark Pharmaceuticals, Inc.

Jul 27, 2017, 08:00 ET